Dopamine increases interleukin 6 release and inhibits tumor necrosis factor release from rat adrenal zona glomerulosa cells in vitro

European Journal of Endocrinology

Volumn 134, Issue 5, 1996, Pages 610-616

  Ritchie, Paul K ^a   Ashby, Marilyn ^a   Knight, Heather H ^a   Judd, Allan M ^a  

^a BRIGHAM YOUNG UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; CORTICOTROPIN; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPOPOLYSACCHARIDE; ROTIGOTINE; TUMOR NECROSIS FACTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FEMALE; NONHUMAN; PRIORITY JOURNAL; RAT; ZONA GLOMERULOSA;

EID: 0029889162     PISSN: 08044643     EISSN: None     Source Type: Journal    
DOI: 10.1530/eje.0.1340610     Document Type: Article

References (45)

1. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990;8:253-78
2. Tracey KJ, Vlassara H, Cerami A. Cachectin/tumour necrosis factor. Lancet 1989;i:1112-26
3. Wilder RL. Neuroendocrine-immune system interactions and autoimmunity. Annu Rev Immunol 1995;13:307-38
4. Judd AM, Macleod RM. The regulation of interleukin-6 and tumor necrosis factor release from primary cultures of ovarian cells. Prog NeuroEndocrinImmun 1992;5:245-55
5. Gorospe WC, Hughes Jr FM, Spangelo BL. Interleukin-6: effects on and production by rat granulosa cells in vitro. Endocrinology 1992;130:1750-2
6. Zolti M, Shemesh M, Wollach D, Mashiach S, Shore L, Rafael ZB. Granulosa cells as a source and target organ for tumor necrosis factor-α. FEBS Lett 1990;261:253-5
7. Schultzberg M, Andersson C, Undén A, Troye-Blomberg M. Interleukin-1 in adrenal chromaffin cells. Neuroscience 1989;30: 805-10
8. Judd AM, MacLeod RM. Angiotensin II increases interleukin 6 release from rat adrenal zona glomerulosa cells. Prog NeuroEndocrinImmunol 1991;4:240-7
9. Judd AM, MacLeod RM. Adrenocorticotropin increases interleukin-6 release from rat adrenal zona glomerulosa cells. Endocrinology 1992;130:1245-54
10. Judd AM, Spangelo BL, MacLeod RM. Rat adrenal zone glomerulosa cells produce interleukin-6. Prog Neuro-EndocrinImmunol 1990;3:282-92
11. Judd AM, MacLeod RM. Differential release of tumor necrosis factor and IL-6 from adrenal zona glomerulosa cells in vitro. Am J Physiol 1995;268:E114-20
12. González-Hernández JA, Bronstein SR, Ehrhart-Bornstein M, Spath-Schwalbe E, Jirikowski G, Scherbaum WA. Interleukin-6 messenger ribonucleic acid expression in human adrenal gland in vivo: new clue to a paracrine or autocrine regulation of adrenal function. J Clin Endocrinol Metab 1994;79:1492-7
13. González-Hernández JA, Ehrhart-Bornstein M, Scherbaum WA, Bornstein SR. Human adrenal cells express TNFα-mRNA: evidence for a paracrine control of adrenal function. 77th Annu Meet Endocr Soc, Washington, DC, 1995. Abstract P3-573
14. Natarajan R, Ploszaj S, Horton R, Nadler J. Tumor necrosis factor and interleukin-1 are potent inhibitors of angiotensin II-induced aldosterone synthesis. Endocrinology 1989;125:3084-9
15. Jäättelä M, Carpén O, Stenman U-H, Saksela E. Regulation of ACTH-induced steroidogenesis in human fetal adrenals by rTNF-α. Mol Cell Endocrinol 1990;68:R31-6
16. Jäättelä M, Ilvesmäki V, Voutilainen R, Ulf-Håkan S, Saksela E. Tumor necrosis factor as a potent inhibitor of adrenocorticotropin-induced cortisol production and steroidogenic P 450 enzyme gene expression in cultured human fetal adrenal cells. Endocrinology 1991;128:623-9
17. Salas MA, Evans SW, Levell MJ, Whicher JT. Interleukin-6 and ACTH act synergistically to stimulate the release of corticosterone from adrenal gland cells. Clin Exp Immunol 1990;79:470-3
18. Judd AM, Ritchie PC. Tumor necrosis factor increases interleukin-6 release from adrenal zona glomerulosa cells in vitro. Endocrine 1995;3:725-8
19. Cuche JL. Dopaminergic control of aldosterone secretion. State-of-the-art review. Fundam Clin Pharmacol 1988;2:327-39
20. Edwards CRW, Miall PA, Hanker JP, Thorner MO. Al-Dujaili EAS, Besser GM. Inhibition of plasma aldosterone response to frusemide by bromocryptine. Lancet 1975;II:903-5
21. Carey RM, Thorner MO, Ortt EM. Effect of metoclopramide and bromocriptine on the renin-angiotensin aldosterone system in man: dopaminergic control of aldosterone. J Clin Invest 1979; 63:727-35
22. Fraser R, Connell JCM, Inglis G, Kenyon CJ, Tree M. The role of dopamine in the control of corticosteroid secretion and metabolism. J Steroid Biochem 1989;32:217-22
23. Morra M, Leboulenger F, Vaudry H. Characterization of dopamine receptors associated with steroid secretion in frog adrenocortical cells. J Mol Endocrinol 1992;8:43-52
24. Kuchel O, Buu NT, Wang P-C. Stress, catecholamines and hypertension: respective role of free and conjugated catecholamines. Stress 1982;3:22-9
25. Bornstein SR, González-Hernández JA, Ehrhart-Bornstein M, Alder G, Scherbaum WA. Intimate contact of chromaffin and cortical cells within the human adrenal gland forms the cellular basis for important intraadrenal interactions. J Clin Endocrinol Metab 1994;78:225-32
26. Bornstein SR, Ehrhart-Bornstein M, Scherbaum WA, Pfeiffer EF, Holst JJ. Effects of splanchnic nerve stimulation on the adrenal cortex may be mediated by chromaffin cells in a paracrine manner. Endocrinology 1990;127:900-6
27. Gwosdow AR, O'Connell NA, Spencer JA, Kumar MSA, Agarwal RK, Bode HH, et al. Interleukin-1-induced corticosterone release occurs by an adrenergic mechanism from rat adrenal gland. Am J Physiol 1992;263:E461-6
28. Walker S, Lightly ERT, Milner SW, Williams BC. Catecholamine stimulation of cortisol secretion by 3-day primary cultures of purified zona fasciculata/reticularis cells isolated from bovine adrenal cortex. Mol Cell Endocrinol 1988;57:139-47
29. Ehrhart-Bornstein M, Bornstein SR, Güse-Behling H, Stromeyer HG, Rasmussen TN, Scherbaum WA, et al. Sympathoadrenal regulation of adrenal androstenedione release. Neuroendocrinology 1994;59:406-12
30. Buu NT, Lussier C. Origin of dopamine in the rat adrenal cortex. Am J Physiol 1990;258:F287-91
31. Inglis GC, Kenyon CJ, Hannah JAM, Connell JMC, Ball SG. Does dopamine regulate aldosterone secretion in the rat? Clin Sci 1987;73:93-7
32. Spangelo BL, Judd AM, Isakson PC, MacLeod RM. Interleukin-1 stimulates interleukin-6 release from rat anterior pituitary cells in vitro. Endocrinology 1991;128:2685-92
33. Wallenstein S, Zucker CL, Fleiss JL. Some statistical methods useful in circulation research. Circ Res 1980;47:1-9
34. Aguilera G, Mendelsohn FAO, Catt KJ. Dopaminergic regulation of aldosterone secretion. Front Neuroendocrinol 1984;8:265-93
35. Porter ID, Whitehouse BJ, Price GM, Hinson JP, Vinson GP. Effects of dopamine, high potassium concentration and field stimulation on the secretion of aldosterone by the perfused rat adrenal gland. J Endocrinol 1992;133:275-82
36. Lamberts SWJ, MacLeod RM. Regulation of PRL secretion at the level of the lactotroph. Physiol Rev 1990;70:279-325
37. Gallo-Payet N, Chouinard L, Balestoe MN, Guillon G. Mechanisms involved in the interaction of dopamine with angiotensin II on aldosterone secretion in isolated and cultured rat adrenal cells. Mol Cell Endocrinol 1991;69:11-23
38. Muramami N, Fukata J, Tsukada T, Kobayashi H, Ebisui O, Segawa H, et al. Bacterial lipopolysaccharide-induced expression of interleukin-6 messenger ribonucleic acid in the rat hypothalamus, pituitary, adrenal gland, and spleen. Endocrinology 1993;133:2574-8
39. Morikawa K, Oseko F, Morikawa S. Immunosuppressive activity of bromocriptine on human T lymphocyte function in vitro. Clin Exp Immunol 1994;95:514-8
40. Boukhris W, Kouassi E, Revillard JP. Differential effect of mixed D1/D2 and selective D2 dopaminergic antagonists on mouse T and B lymphocyte proliferation and interleukin production in vitro. Immunopharmacol Immunotoxicol 1988;10:501-12
41. Yeasting RA. Selected morphological aspects of human suprarenal glands. In: Mulrow PJ, editor. The adrenal gland. New York: Elsevier, 1985:45-63
42. Darling G, Goldstein DS, Stull R, Gorschboth CM, Norton JA. Tumor necrosis factor: immune endocrine interactions. Surgery 1989;106:1155-60
43. Aderka D, Le J, Vilček J. Interleukin-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 1989;143:3517-23
44. Barton BE, Jackson JV. Protective role of interleukin-6 in the lipopolysaccharide-galactosamine septic shock model. Infect Immun 1993;61:1496-9
45. Tilg H, Trehu E, Atkins MB, Dinarello CA, Mier JW. Interleukin-6 (IL-6) as an anti-inflammatory cytokine: induction of circulating IL-1 receptor antagonist and soluble tumor necrosis factor receptor p55. Blood 1994;83:113-8